Highlights
A collection of news and information related to IMS Health Incorporated published by this site and its partners.
Displaying items 1-12 of 46
» View wsbt.com items only
1
2
3
4
•
Next >
-
New cancer tools allow patients to reconsider chemo
ReutersLOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments. An approach to oncology that has been in place...Tags: Leukemia, Skin Cancer, Medical Research, Biotechnology, Cancer
-
Combined supplements no better for cholesterol
ReutersNEW YORK (Reuters Health) - Adding a plant-derived compound called a sterol to the cholesterol-lowering agent red yeast rice doesn't make it work any better, according to a new study. "I expected to see a synergistic effect with red yeast rice, and I was...Tags: Diseases and Illnesses, Placebo, Medical Research, Health and Medical Professionals, Cardiologists
-
REUTERS SUMMIT-Teva better suited than most for China market -CEO
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Bill Berkrot NEW YORK, May 6 (Reuters) - Teva Pharmaceutical Industries Ltd has yet to make any serious inroads into China, but its chief executive...Tags: Environmental Illness, Israel, Corporate Officers, Novartis AG, Bristol Myers Squibb Company
-
Questions remain after judge lifts age limit on Plan B
With a federal judge clearing away age restrictions on purchasing emergency contraception, many Chicago-area health care providers, teens and others are preparing for more accessibility — even if they're not exactly sure how the drug will be made...
Tags: Food and Drug Administration, Health Treatments, Birth Control, Plan B (drug), Health and Medical Professionals
-
Actavis settles OxyContin lawsuit with Purdue
ReutersApril 26 (Reuters) - Generic drugmaker Actavis Inc said it had settled a patent lawsuit with Purdue Pharma related to Actavis' generic version of the abuse-deterrent formulation of Purdue's painkiller OxyContin. Under the agreement, Actavis will be...Tags: Justice System, Drugs and Medicines, New Products, Watson Pharmaceuticals Incorporated, OxyContin (drug)
-
U.S. judge widens 'morning-after' pill access for young girls
ReutersNEW YORK (Reuters) - A federal judge on Friday ordered the U.S. Food and Drug Administration to make "morning-after" emergency contraception pills available without a prescription to all girls of reproductive age and criticized the Obama administration...Tags: Food and Drug Administration, Politics, Gynecology, Health and Medical Professionals, Judges
-
Diabetes cases hit record and half go undiagnosed
ReutersLONDON (Reuters) - Diabetes is running at record levels worldwide and half the people estimated to have the disease are, as yet, undiagnosed, according to a report on Wednesday. The number of people living with diabetes is now put at 371 million, up from...Tags: Respiratory Disease, Diseases and Illnesses, Insulin, Obesity, Diabetes
-
Sleeping pills linked to higher risk of cancer, death, study says
A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem (Ambien), temazepam (Restoril), eszopiclone (Lunesta) and zaleplon (Sonata) are more likely to develop cancer, and far more likely to die...Tags: Food and Drug Administration, Human Body, Medical Research, Lymphoma, Lungs and Airways
-
|Story
-
|Story
-
FDA favors more risk information on birth control pills
WASHINGTON (AP) -- Federal health regulators are leaning toward adding new information about the risk of blood clots to the labels of widely prescribed birth control pills such as Yaz, in light of growing evidence suggesting the newer contraceptive...Tags: Food and Drug Administration, Health Treatments, Birth Control, Yaz (drug), Pregnancy and Childbirth
-
The Big One is going generic
HealthThe nation's largest-selling pharmaceutical is going generic this week. Lipitor, which is prescribed to help people reduce their cholesterol levels, is going "off-patent" Wednesday. According to a HealthDay News report, Lipitor sales were nearly $4...
May 15, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
May 6, 2013
|Story| Reuters
Apr 24, 2013
|Story| Chicago Tribune
Apr 26, 2013
|Story| Reuters
Apr 5, 2013
|Story| Reuters
Nov 13, 2012
|Story| Reuters
Feb 28, 2012
|Story| Los Angeles Times
Jan 10, 2012
|Story| Los Angeles Times
Feb 2, 2012
|Story| South Florida Sun-Sentinel
Dec 6, 2011
|Story| Petoskey News
Nov 29, 2011
| Allentown Morning Call
Original site for IMS Health Incorporated topic gallery.
